The market climbed Friday after a week of waiting and reacting to Nvidia earnings and Bitcoin's all-time highs. The market overall advanced Friday. Just past 4 pm ET the$S&P 500 Index (.SPX.US)$traded +0.35%, the$Dow Jones Industrial Average (.DJI.US)$climbed 0.97%, and the$Nasdaq Composite Index (.IXIC.US)$climbed 0.16%. MACRO In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...
Good morning, traders. Happy Friday, November 22nd. Without the news and animal spirits moving markets, you will not make it through today. My name is Kevin Travers, and the S&P 500 and market climbed this morning, here is what's moving: $Super Micro Computer (SMCI.US)$climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...
Kevin Travers
OP
Mrstocksplitsundae
:
I write a daily market update as a writer at moomoo that I send to every S&P 500 stock page, do you find market information not related to market prices?
$Replimune (REPL.US)$Reuters· 3 mins ago Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway
$Replimune (REPL.US)$Replimune: Positive Topline Primary Analysis Data by Independent Central Review From Ignyte Trial of Rp1 Plus Nivolumab in Anti-Pd1 Failed Melanoma! Intends to submit BLA in 2H 2024
Report
No comment yet
- No more -
Sign in to post a comment
Trending Stocks
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Replimune Stock Forum
The market overall advanced Friday. Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.35%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.97%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.16%.
MACRO
In macroeconomics, S&P Global released its composite and service PMI. Composite came in at a two-year high, 55.3...
$Super Micro Computer (SMCI.US)$ climbed 15%, after earlier this week, the firm said it submitted a plan to release its six-month delayed 10k with a new auditor, BDO USA, and filed for a time extension to file it...
Replimune Receives Breakthrough Therapy Designation for Rp1 and Submits Rp1 Biologics License Application to the FDA Under the Accelerated Approval Pathway
No comment yet